Latest releases
May 23, 2017:
Data on LTX-315 has been accepted for poster presentation at ASCO 2017
May 21, 2017:
Immunotherapeutic effects of LTX-315 published in Future Medicinal Chemistry
Apr 21, 2017:
Lytix Biopharma completes 1st combination cohort of LTX-315 and pembrolizumab in TNBC
Apr 20, 2017:
Lytix Biopharma raises in total 80 million NOK